
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1
0:00
3:54
Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
More episodes from "Clinical Journal of the American Society of Nephrology (CJASN)"



Don't miss an episode of “Clinical Journal of the American Society of Nephrology (CJASN)” and subscribe to it in the GetPodcast app.








